Purpose: Micropapillary carcinoma (MPC) is a recognised histopathological subtype associated with aggressive biological behaviour and poor prognosis in colorectal cancer (CRC). Despite formal recognition by the World Health Organization since 2010, its clinical significance remains underappreciated in surgical literature, potentially hindering biologically informed decision-making. The aim of this study was to assess the degree of awareness and representation of MPC in colorectal cancer across medical disciplines, and to determine whether surgical publications have lagged behind other specialties. Methodology: A cross-sectional bibliometric analysis of PubMed publications from 2013-2023 was conducted. The search strategy used the terms “micropapillary” and “colorectal,” “colon,” or “rectal cancer.” Studies were eligible if MPC was the central focus. Articles were categorised according to the disciplinary scope of the publishing journal (Pathology, Medicine, Oncology or Surgery). The cumulative publication output and temporal trends were analysed. Results: Of 612 initial publications, 187 met inclusion criteria, with 17 focused on CRC-MPC. Cumulative disciplinary representation was: Pathology (n=7,41%), Medicine (n=6,35%), Oncology (n=3,18%), and Surgery (n=1,6%). Surgical publications rarely examined operative or prognostic implications, whereas pathology and oncology journals increasingly explored molecular and morphological correlates, including associations with lymphovascular invasion, epithelial–mesenchymal transition and high-risk Stage II disease. Conclusion: Awareness of CRC-MPC has expanded within pathology and oncology literature but remains minimal within surgical scholarship. This disciplinary lag underscores a broader gap between emerging tumour biology and its integration into surgical decision-making. Recognising MPC in preoperative and resection specimens could refine prognostication, guide the extent of resection and inform adjuvant therapy.